Clinical Trial Update: Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating Olaparib and Durvalumab with carboplatin, etoposide, and optional radiation therapy for extensive-stage small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• IMFINZI (DURVALUMAB)
• Lynparza (olaparib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING